Early treatment of patients with undifferentiated arthritis (UA) with Methotrexate (MTX).
Completed
- Registration Number
- NL-OMON23294
- Brief Summary
Arthritis Rheum. 2007 May;56(5):1424-32.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 110
Inclusion Criteria
1. Diagnosis probable RA according to the ACR-1958 criteria;
2. Aged 18 years or older;
Exclusion Criteria
1. Diagnosis RA according to the ACR-1987 criteria;
2. Kidney disorder: creatinine >150umol/l or estimated clearance < 75;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome is diagnosis after phasing out the study medication: <br /> rheumatoid arthritis, persisting undifferentiated arthritis or remission.
- Secondary Outcome Measures
Name Time Method Secondary outcome values are (progression of) joint damage of hands and feet, disease activity and functional capacity.